Covington Advises AstraZeneca in $1.26 Billion Acquisition of Ardea Biosciences
WASHINGTON, April 23, 2012 /PRNewswire/ -- Covington & Burling represented AstraZeneca in its $1.26 billion acquisition of Ardea Biosciences. Under the agreement, AstraZeneca will pay $32 per share for all of the outstanding shares of Ardea.
AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease. Ardea is a biotechnology company based in San Diego, California, focused on the development of small-molecule therapeutics for the treatment of serious diseases.
The Covington team was led by Catherine Dargan , with assistance from Stephen Infante and Michael Riella . The team also included John Hurvitz , Emily Leonard , Ashley Nelson , Darien Capron , Brianna Sandoval , Christina Chung , Larry Bartenev and Caitlin Cottingham (life sciences/corporate), Robert Heller and Sarah Burnham (tax), Michael Francese and Katherine Mineka (benefits), Marialuisa Gallozzi and Scott Levitt (insurance), Andrea Reister and Marie Lavalleye (intellectual property), Michael Labson (regulatory), and Deborah Garza , James Dean and Jonathan Herczeg (antitrust).
Covington & Burling LLP, an international law firm, provides corporate, litigation, and regulatory expertise to enable clients to achieve their goals. Founded in 1919, the firm has more than 800 lawyers and offices in Beijing, Brussels, London, New York, San Diego, San Francisco, Silicon Valley, and Washington, DC.
SOURCE Covington & Burling
More by this Source
Covington assessora Grupo Sura em aquisição de US$ 516 milhões
Apr 24, 2013, 13:30 ET
Covington asesora al Grupo Sura en una adquisición de USD516 millones
Apr 24, 2013, 01:10 ET
Covington Advises Grupo Sura in $516 Million Acquisition
Apr 23, 2013, 19:37 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.